MENU Quick Go

  • HOME
  • News
  • PharmAbcine Notice
PharmAbcine Notice
PharmAbcine`s ``BI(Business Incubation) Research Grant`` proposal is granted by KIAT.
Date 2017-07-07 Hit 749
Attach Files  

PharmAbcine`s "BI(Business Incubation) Research Grant" proposal is granted by KIAT (https://www.kiat.or.kr/site/main/main.jsp) and PharmAbcine will use this research funding to generate the second generation of PMC-001(DIG-KT) to get ready to out-license. The first generation version of PMC-001(DIG-KT) has been out-licensed to 3SBio for both Korea and China market in 2015.The CEO and CFO of PharmAbcine are going to participate the BI Research Grant workshop organized by KIAT and will have 1-to 1 partnering meetings with investors and  business partners on July 13-14, 2017.


Reference:

http://www.prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-for-dig-kt-a-bi-specific-mab-targeting-vegfr2-and-tie-2-with-pharmabcine-300020495.html

http://bciq.biocentury.com/products/dig-kt

http://whosaeng.com/sub_read.html?uid=71563

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499296/

http://eng.kddf.org/bbs/bbs.asp?mode=view&IDX=717&p=1&cateId=35

http://www.worldbil.com/CTIP2015/Download/8.pdf

 

List